HealthCor Management L.P. raised its position in shares of Medtronic plc. (NYSE:MDT) by 2,850.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,950,000 shares of the medical technology company’s stock after acquiring an additional 1,883,900 shares during the period. Medtronic makes up 5.1% of HealthCor Management L.P.’s portfolio, making the stock its 6th biggest holding. HealthCor Management L.P.’s holdings in Medtronic were worth $157,463,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. Willis Investment Counsel lifted its stake in Medtronic by 0.3% during the second quarter. Willis Investment Counsel now owns 97,961 shares of the medical technology company’s stock worth $8,694,000 after purchasing an additional 296 shares during the period. Mariner Wealth Advisors LLC lifted its stake in Medtronic by 9.3% during the second quarter. Mariner Wealth Advisors LLC now owns 17,239 shares of the medical technology company’s stock worth $1,530,000 after purchasing an additional 1,463 shares during the period. GQG Partners LLC bought a new position in Medtronic during the second quarter worth about $4,392,000. Bluestein R H & Co. lifted its stake in Medtronic by 6.3% during the second quarter. Bluestein R H & Co. now owns 318,231 shares of the medical technology company’s stock worth $28,243,000 after purchasing an additional 18,764 shares during the period. Finally, South Street Advisors LLC lifted its stake in Medtronic by 768.2% during the second quarter. South Street Advisors LLC now owns 112,509 shares of the medical technology company’s stock worth $9,985,000 after purchasing an additional 99,550 shares during the period. Institutional investors own 80.79% of the company’s stock.

How to Become a New Pot Stock Millionaire

In other Medtronic news, EVP Hooman Hakami sold 26,158 shares of the firm’s stock in a transaction that occurred on Friday, January 5th. The shares were sold at an average price of $85.00, for a total value of $2,223,430.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Carol A. Surface sold 24,479 shares of the firm’s stock in a transaction that occurred on Monday, March 5th. The shares were sold at an average price of $78.18, for a total transaction of $1,913,768.22. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 145,163 shares of company stock worth $12,232,045. Insiders own 0.31% of the company’s stock.

A number of research analysts have commented on the stock. SunTrust Banks set a $92.00 price target on shares of Medtronic and gave the stock a “buy” rating in a research note on Sunday, November 19th. Citigroup restated a “buy” rating and set a $93.00 price target (down previously from $100.00) on shares of Medtronic in a research note on Thursday, February 22nd. Northland Securities restated a “hold” rating and set a $80.00 price target on shares of Medtronic in a research note on Wednesday, November 22nd. TheStreet cut shares of Medtronic from a “b” rating to a “c+” rating in a research note on Tuesday, February 20th. Finally, Zacks Investment Research upgraded shares of Medtronic from a “sell” rating to a “hold” rating in a research note on Thursday, November 23rd. One analyst has rated the stock with a sell rating, eight have given a hold rating and sixteen have given a buy rating to the stock. Medtronic currently has an average rating of “Buy” and a consensus target price of $91.50.

Shares of Medtronic plc. (NYSE:MDT) opened at $83.15 on Monday. The company has a quick ratio of 2.09, a current ratio of 2.43 and a debt-to-equity ratio of 0.51. The firm has a market cap of $112,699.27, a P/E ratio of 17.73, a P/E/G ratio of 2.36 and a beta of 0.97. Medtronic plc. has a fifty-two week low of $76.51 and a fifty-two week high of $89.72.

Medtronic (NYSE:MDT) last issued its quarterly earnings results on Tuesday, February 20th. The medical technology company reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.16 by $0.01. The business had revenue of $7.37 billion during the quarter, compared to analyst estimates of $7.20 billion. Medtronic had a net margin of 9.44% and a return on equity of 12.65%. Medtronic’s revenue for the quarter was up 1.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.12 earnings per share. research analysts expect that Medtronic plc. will post 4.75 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: “HealthCor Management L.P. Grows Holdings in Medtronic plc. (MDT)” was reported by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international copyright and trademark laws. The correct version of this piece of content can be viewed at https://www.dailypolitical.com/2018/03/12/healthcor-management-l-p-grows-holdings-in-medtronic-plc-mdt.html.

Medtronic Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Want to see what other hedge funds are holding MDT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medtronic plc. (NYSE:MDT).

Institutional Ownership by Quarter for Medtronic (NYSE:MDT)

Receive News & Ratings for Medtronic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic and related companies with MarketBeat.com's FREE daily email newsletter.